Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · IEX Real-Time Price · USD

8.00

-0.12 (-1.48%)

At close: Jul 19, 2024, 4:00 PM

7.89

-0.11 (-1.38%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Fulcrum Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Revenue	2.51	2.81	6.34	19.16	8.82	0	Upgrade
Revenue Growth (YoY)	-37.95%	-55.77%	-66.90%	117.19%	-	-	Upgrade
Gross Profit	2.51	2.81	6.34	19.16	8.82	0	Upgrade
Selling, General & Admin	40.21	41.67	41.69	30.52	21.39	13.15	Upgrade
Research & Development	74.86	71.8	76.78	69.7	59.04	71.07	Upgrade
Other Operating Expenses	0	0	0.43	0	0	0	Upgrade
Operating Expenses	115.07	113.47	118.9	100.22	80.43	84.22	Upgrade
Operating Income	-112.56	-110.66	-112.56	-81.05	-71.61	-84.22	Upgrade
Other Expense / Income	-13.13	-13.33	-2.69	-0.21	-0.79	-1.54	Upgrade
Pretax Income	-99.43	-97.34	-109.87	-80.85	-70.82	-82.68	Upgrade
Net Income	-99.43	-97.34	-109.87	-80.85	-70.82	-82.68	Upgrade
Preferred Dividends	0	0	0	0	0	7.13	Upgrade
Net Income Common	-99.43	-97.34	-109.87	-80.85	-70.82	-89.81	Upgrade
Shares Outstanding (Basic)	62	61	45	35	25	11	Upgrade
Shares Outstanding (Diluted)	62	61	45	35	25	11	Upgrade
Shares Change	3.79%	36.27%	27.23%	39.47%	129.53%	778.76%	Upgrade
EPS (Basic)	-1.60	-1.59	-2.44	-2.29	-2.79	-8.13	Upgrade
EPS (Diluted)	-1.60	-1.59	-2.44	-2.29	-2.79	-8.13	Upgrade
Free Cash Flow	-92.5	-91.47	-99.01	-80.19	-55	-40.34	Upgrade
Free Cash Flow Per Share	-1.49	-1.49	-2.20	-2.27	-2.17	-3.65	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-4484.38%	-3945.24%	-1774.85%	-422.97%	-811.64%	-	Upgrade
Profit Margin	-3961.20%	-3470.05%	-1732.43%	-421.89%	-802.66%	-	Upgrade
Free Cash Flow Margin	-3685.18%	-3261.07%	-1561.23%	-418.47%	-623.34%	-	Upgrade
EBITDA	-97.34	-95.16	-107.46	-78.33	-68.44	-80.62	Upgrade
EBITDA Margin	-3878.13%	-3392.62%	-1694.37%	-408.77%	-775.70%	-	Upgrade
Depreciation & Amortization	2.09	2.17	2.41	2.52	2.38	2.05	Upgrade
EBIT	-99.43	-97.34	-109.87	-80.85	-70.82	-82.68	Upgrade
EBIT Margin	-3961.20%	-3470.05%	-1732.43%	-421.89%	-802.66%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).